Hope for aggressive breast cancers as diabetes drug creates new potential avenue for treatment

New research funded by Breast Cancer Now has shown that a drug commonly used to treat Type 2 diabetes could make breast cancer cells susceptible to...

23 June 2019

Night shifts do not increase breast cancer risk, major UK analysis suggests

In a new ten-year study of more than 100,000 women, funded by Breast Cancer Now, researchers examined extensive details of women’s night shift work,...

29 May 2019

Scottish trial to train radiographers to help reduce patients’ fears of breast cancer returning

Researchers at the University of St Andrews have been awarded over £110,000 by charity Breast Cancer Now in partnership with the Scottish Government’...

21 May 2019

Facebook Live Broadcasts Reach Over Quarter of Million Seeking Support

Leading charity Breast Cancer Care and Breast Cancer Now has reached over 290,000 people with expert clinical information and support in its first...

20 May 2019

Professor Andrew Tutt recognised for his outstanding contribution to research

All of us at Breast Cancer Now are delighted to hear that Professor Andrew Tutt, Director of the Breast Cancer Now Toby Robins Research Centre at The...

9 May 2019

Pink Ribbon Ball 2018

Tickets are now available for purchase for our Pink Ribbon Silver Anniversary Ball in November! For those of you who couldn’t come last year, here...

25 April 2019

Simple test could predict response to anthracycline chemotherapy for patients with ‘triple negative’ breast cancer

A new biomarker could predict whether a common type of chemotherapy will be effective for patients with ‘triple negative’ breast cancer and help to...

10 April 2019

Charity event thanks lifestyle coaches for their support in pioneering Scottish breast cancer risk trial

On Thursday 21 March, we held an event at the V&A in Dundee to thank 45 volunteer lifestyle coaches for their involvement in the pioneering...

26 March 2019

PARP inhibitors could boost the effect of immunotherapies

PARP inhibitors are a type of targeted therapy currently used to treat BRCA-mutated ovarian cancer and have been approved for treatment of advanced...

11 March 2019